JS-K, a glutathione/glutathione S-transferase-activated nitric oxide releasing prodrug inhibits androgen receptor and WNT-signaling in prostate cancer cells
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
JS-K, a glutathione/glutathione S-transferase-activated nitric oxide releasing prodrug inhibits androgen receptor and WNT-signaling in prostate cancer cells
Authors
Keywords
-
Journal
BMC CANCER
Volume 12, Issue 1, Pages -
Publisher
Springer Nature
Online
2012-03-31
DOI
10.1186/1471-2407-12-130
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Inhibition of Glycogen Synthase Kinase-3 in Androgen-Responsive Prostate Cancer Cell Lines: Are GSK Inhibitors Therapeutically Useful?
- (2015) Ludwig Rinnab et al. NEOPLASIA
- Alternatively spliced androgen receptor variants
- (2011) Scott M Dehm et al. ENDOCRINE-RELATED CANCER
- Characterising the castration-resistant prostate cancer population: a systematic review
- (2011) M. Kirby et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- Inhibition of Glycogen Synthase Kinase-3β Counteracts Ligand-Independent Activity of the Androgen Receptor in Castration Resistant Prostate Cancer
- (2011) Stefanie V. Schütz et al. PLoS One
- JS-K; a nitric oxide-releasing prodrug, modulates β-catenin/TCF signaling in leukemic Jurkat cells: Evidence of an S-nitrosylated mechanism
- (2010) Niharika Nath et al. BIOCHEMICAL PHARMACOLOGY
- Cancer Statistics, 2010
- (2010) A. Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- JS-K has potent anti-angiogenic activityin vitroand inhibits tumour angiogenesis in a multiple myeloma modelin vivo
- (2010) Tanyel Kiziltepe et al. JOURNAL OF PHARMACY AND PHARMACOLOGY
- Nitric Oxide Inhibits the Proliferation and Invasion of Pancreatic Cancer Cells through Degradation of Insulin Receptor Substrate-1 Protein
- (2010) H. Sugita et al. MOLECULAR CANCER RESEARCH
- Nitric Oxide-Releasing Silica Nanoparticle Inhibition of Ovarian Cancer Cell Growth
- (2010) Ellen V. Stevens et al. MOLECULAR PHARMACEUTICS
- Limitations of MTT and MTS-Based Assays for Measurement of Antiproliferative Activity of Green Tea Polyphenols
- (2010) Piwen Wang et al. PLoS One
- Constitutively active androgen receptor splice variants expressed in castration-resistant prostate cancer require full-length androgen receptor
- (2010) P. A. Watson et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Nitro-aspirin inhibits MCF-7 breast cancer cell growth: Effects on COX-2 expression and Wnt/β-catenin/TCF-4 signaling
- (2009) Niharika Nath et al. BIOCHEMICAL PHARMACOLOGY
- Recent Advances on the Roles of NO in Cancer and Chronic Inflammatory Disorders
- (2009) Jagat Kanwar et al. CURRENT MEDICINAL CHEMISTRY
- Biochemical and cellular toxicology of peroxynitrite: implications in cell death and autoimmune phenomenon
- (2009) Rizwan Ahmad et al. IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY
- Phase II Study of Nitric Oxide Donor for Men With Increasing Prostate-specific Antigen Level After Surgery or Radiotherapy for Prostate Cancer
- (2009) D. Robert Siemens et al. UROLOGY
- Splicing of a Novel Androgen Receptor Exon Generates a Constitutively Active Androgen Receptor that Mediates Prostate Cancer Therapy Resistance
- (2008) S. M. Dehm et al. CANCER RESEARCH
- Crosstalk between the Androgen Receptor and -Catenin in Castrate-Resistant Prostate Cancer
- (2008) G. Wang et al. CANCER RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started